INT340751

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.20
First Reported 2010
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 1
Total Number 7
Disease Relevance 12.05
Pain Relevance 0.49

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

DLEU1 (Homo sapiens)
Pain Link Frequency Relevance Heat
Neuropeptide 14 99.52 Very High Very High Very High
imagery 14 99.18 Very High Very High Very High
cocaine 7 98.48 Very High Very High Very High
Pain 7 71.92 Quite High
Inflammation 21 71.56 Quite High
substance P 7 67.80 Quite High
Enkephalin 7 67.16 Quite High
Inflammatory marker 7 57.20 Quite High
Dopamine 70 46.40 Quite Low
Neurotransmitter 21 38.16 Quite Low
Disease Link Frequency Relevance Heat
Parkinson's Disease 1085 100.00 Very High Very High Very High
Disease 875 99.80 Very High Very High Very High
Cognitive Disorder 98 99.16 Very High Very High Very High
Alzheimer's Dementia 126 95.32 Very High Very High Very High
Syndrome 49 94.60 High High
Dementia 434 94.24 High High
Neurodegenerative Disease 91 92.40 High High
Aging 21 90.40 High High
Frailty 21 89.92 High High
Vascular Dementia 63 85.08 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Not surprisingly, our searches for DLB CSF biomarkers highlighted a number of studies that included PD and PDD subjects.
DLB Binding (searches) of associated with parkinson's disease and disease
1) Confidence 0.20 Published 2010 Journal International Journal of Alzheimer's Disease Section Body Doc Link PMC2965495 Disease Relevance 1.63 Pain Relevance 0
Thus, any alterations in molecular patterns associated with these characteristic morphological changes can be useful in developing a biomarker for DLB.
DLB Binding (biomarker) of associated with parkinson's disease
2) Confidence 0.18 Published 2010 Journal International Journal of Alzheimer's Disease Section Body Doc Link PMC2965495 Disease Relevance 1.69 Pain Relevance 0.40
-synuclein measures were significantly correlated with duration of the DLB (P <?.
DLB Binding (duration) of associated with parkinson's disease
3) Confidence 0.18 Published 2010 Journal International Journal of Alzheimer's Disease Section Body Doc Link PMC2965495 Disease Relevance 1.22 Pain Relevance 0
While these studies may not ultimately highlight a suitable biomarker for DLB, they should be considered, even if only for evidence of further exclusion criteria.


DLB Neg (not) Binding (biomarker) of associated with parkinson's disease
4) Confidence 0.18 Published 2010 Journal International Journal of Alzheimer's Disease Section Body Doc Link PMC2965495 Disease Relevance 1.74 Pain Relevance 0
In contrast, in AD (but not DLB and PDD) there was a slight increase in CSF A?
DLB Binding (was) of associated with parkinson's disease and disease
5) Confidence 0.18 Published 2010 Journal International Journal of Alzheimer's Disease Section Body Doc Link PMC2965495 Disease Relevance 1.94 Pain Relevance 0.04
42 levels comes from a PET imaging study, which demonstrated that the PIB binding in DLB was associated with cognitive impairment (P = .0006) and decrease in CSF A?
DLB Binding (binding) of associated with parkinson's disease, cognitive disorder and imagery
6) Confidence 0.18 Published 2010 Journal International Journal of Alzheimer's Disease Section Body Doc Link PMC2965495 Disease Relevance 1.74 Pain Relevance 0.05
-synuclein levels as DLB individuals [52].The ?
DLB Binding (individuals) of associated with parkinson's disease
7) Confidence 0.18 Published 2010 Journal International Journal of Alzheimer's Disease Section Body Doc Link PMC2965495 Disease Relevance 2.10 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox